Authors’ Reply to the Letter by Shoar et al. on “Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo” - Archive ouverte HAL Access content directly
Journal Articles Cardiology Year : 2020

Authors’ Reply to the Letter by Shoar et al. on “Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo”

(1, 2) , (1) , (1) , (3, 4)
1
2
3
4

Abstract

No abstract available

Domains

Life Sciences [q-bio]
Embargoed file
Embargoed file
Ne sera jamais visible

Christine Dupuis  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-03090462

Submitted on : Tuesday, December 29, 2020-4:48:58 PM

Last modification on : Tuesday, April 26, 2022-4:14:02 PM

Long-term archiving on: Tuesday, March 30, 2021-7:56:47 PM

Embargoed file
Please log in to request access to the document

Dates and versions

inserm-03090462 , version 1 (29-12-2020)

Identifiers

Cite

Pierre Ambrosi, Aurélie Daumas, Patrick Villani, Roch Giorgi. Authors’ Reply to the Letter by Shoar et al. on “Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo”. Cardiology, 2020, 145 (6), pp.387-387. ⟨10.1159/000507361⟩. ⟨inserm-03090462⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM IRD UNIV-AMU U1252
83 View
2 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More